James McCollum's most recent trade in LENZ Therapeutics Inc. was a trade of 13,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENZ Therapeutics Inc. | James McCollum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | James McCollum | Director | Purchase of securities on an exchange or from another person at price $ 15.99 per share. | 13 May 2024 | 31,332 | 525,565 | - | 16.0 | 501,093 | Common Stock |
| LENZ Therapeutics Inc. | James McCollum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 477,600 | 477,600 | - | 0 | Common Stock | |
| LENZ Therapeutics Inc. | James McCollum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 95,034 | 95,034 | - | 0 | Common Stock | |
| LENZ Therapeutics Inc. | James McCollum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | James McCollum | Director | Grant, award, or other acquisition of securities at price $ 15.03 per share. | 21 Mar 2024 | 16,633 | 494,233 | - | 15.0 | 249,992 | Common Stock |
| LENZ Therapeutics Inc. | James McCollum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 6,575 | 6,575 | - | - | Warrant (right to buy) |